Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mulpleta (lusutrombopag) post-marketing use-results survey in Japan
jRCT1080223377Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lusutrombopag in Thrombocytopenia and chronic liver disease (CLD), sponsored by Shionogi & Co., Ltd. Started Nov 2016; status: completed.
02
Drugs
lusutrombopag
03
Conditions
Thrombocytopeniachronic liver disease (CLD)
Beyond the preview
Go deeper on jRCT1080223377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223377.